Nick White played a key role in ensuring the global recommendation of artemisinin-based combination therapy (ACT) as the most effective treatment for malaria caused by the Plasmodium falciparum parasite. His research and advocacy have transformed the prospects of millions of people, especially children, living in malaria-endemic countries in Africa and Southeast Asia.
Working in Thailand, Nick established research networks tackling tropical infections that include dengue fever and tuberculosis, as well as malaria. Through trials conducted by these networks, Nick was successful in demonstrating the effectiveness against malaria of artemisinin, a plant derivative developed in China, as well as the need to combine it with other drugs to avoid the development of resistance.
Nick continues to work on drug resistance and the pathophysiology of severe malaria. He advises the World Health Organization on malaria treatment, and advocates the development of research laboratories and public health surveillance in tropical countries. He received the Gairdner Global Health Award in 2010 and Thailand’s Prince Mahidol Award in 2011.
Professor of Tropical Medicine, Faculty Tropical Medicine, Mahidol University
Interest and expertise
Health and human sciences
Clinical pharmacology, Clinical physiology, Medicine, clinical studies, Medical microbiology
Royal Society GlaxoSmithKline Prize and Lecture
For his outstanding work on the treatment and prevention of serious diseases within the developing world.